Table 3.
The clinicopathological relevance analysis of PD-L1+Bregs cell number in HCC patients
| High (N=17) | Low (N=18) | P-value* | |
|---|---|---|---|
| Gender | |||
| Female | 2 (11.8%) | 8 (44.4%) | 0.0776 |
| Male | 15 (88.2%) | 10 (55.6%) | |
| Age | |||
| ≥50 | 14 (82.4%) | 14 (77.8%) | 1 |
| <50 | 3 (17.6%) | 4 (22.2%) | |
| Capsule | |||
| No | 11 (64.7%) | 13 (72.2%) | 0.909 |
| Yes | 6 (35.3%) | 5 (27.8%) | |
| Vessel | |||
| No | 14 (82.4%) | 15 (83.3%) | 1 |
| Yes | 3 (17.6%) | 3 (16.7%) | |
| Child-Pugh stage | |||
| classA | 11 (64.7%) | 16 (88.9%) | 0.194 |
| classB | 6 (35.3%) | 2 (11.1%) | |
| HbsAg | |||
| Negative | 6 (35.3%) | 4 (22.2%) | 0.63 |
| Positive | 11 (64.7%) | 14 (77.8%) | |
| Cirrhosis | |||
| S0 | 1 (5.9%) | 0 (0%) | 0.032 |
| S1 | 3 (17.6%) | 9 (50.0%) | |
| S2 | 2 (11.8%) | 6 (33.3%) | |
| S3 | 4 (23.5%) | 1 (5.55%) | |
| S4 | 7 (41.2%) | 2 (11.1%) | |
| AFP | |||
| Abnormal | 6 (35.3%) | 9 (50.0%) | 0.591 |
| Normal | 11 (64.7%) | 9 (50.0%) | |
| TNM | |||
| I | 2 (11.8%) | 13 (72.2%) | 0.0012 |
| II | 9 (52.9%) | 6 (33.3%) | |
| III | 5 (29.4%) | 0 (0%) |
*
Data was analyzed by chi-squared test.
P value in bold indicated statistically significant.